Jeffrey Bednarski

Medicine & Life Sciences

1. Double-Stranded DNA Breaks 100%
2. B-Lymphocytes 89%
3. DNA Damage 84%
4. Severe Combined Immunodeficiency 84%
5. B-Lymphoid Precursor Cells 73%
6. Bz-423 65%
7. Ataxia Telangiectasia 60%
8. Lymphocytes 54%
9. Antigen Receptors 54%
10. Transplants 53%
11. 1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione 48%
12. Immune Reconstitution 47%
13. Pediatrics 44%
14. Cell Transplantation 41%
15. Benzodiazepines 40%
16. Primary Immunodeficiency Diseases 39%
17. V(D)J Recombination 38%
18. DNA Breaks 37%
19. Alemtuzumab 36%
20. Genes 36%
21. Chronic Granulomatous Disease 35%
22. Hemophagocytic Lymphohistiocytosis 34%
23. Interleukin-7 32%
24. Infections 32%
25. Toxoplasma 29%
26. Tissue Donors 29%
27. Hematopoietic Stem Cells 27%
28. Immunoglobulin Light Chain Genes 27%
29. T-Lymphocytes 26%
30. G1 Phase 25%
31. Neonatal Screening 24%
32. Transcription Factors 24%
33. Germinal Center 23%
34. Hematopoietic Stem Cell Transplantation 23%
35. Phosphotransferases 22%
36. Pre-B Cell Receptors 22%
37. Laurates 22%
38. Toll-Like Receptor 8 21%
39. Transplantation Conditioning 21%
40. Lymphopoiesis 21%
41. Apoptosis 21%
42. Polynucleotide 5'-Hydroxyl-Kinase 20%
43. Phosphatidylinositol 4,5-Diphosphate 20%
44. fludarabine 20%
45. Mutation 20%
46. Bone Marrow Failure Disorders 19%
47. Ehrlichiosis 19%
48. C2 Domains 19%
49. Tetraspanins 19%
50. Thiotepa 19%